Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 2,336,842 | 2,104,181 | 2,055,036 | 1,799,986 | 2,088,349 | 10,384,394 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 2,336,842 | 2,104,181 | 2,055,036 | 1,799,986 | 2,088,349 | 10,384,394 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 5,001,004 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 5,383,390 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 2,336,842 | 2,104,181 | 2,055,036 | 1,799,986 | 2,088,349 | 10,384,394 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 248,335 | 331,180 | 294,198 | 270,016 | 315,175 | 1,458,904 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 11,843,298 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2019 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2019 |
(iii) Distributable Amount for 2019 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2019 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2019: | ||||
| a From 2014....... | ||||
| b From 2015....... | ||||
| c From 2016....... | ||||
| d From 2017....... | ||||
| e From 2018....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2019 distributable amount | ||||
|
i
Carryover from 2014 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2019 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2019 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2019, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2019. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2020. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2015..... | ||||
| b Excess from 2016..... | ||||
| c Excess from 2017..... | ||||
| d Excess from 2018..... | ||||
| e Excess from 2019..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS (CONTINUED) | RESIDENT RESEARCH GRANT $5000 IN GRANTS TO SUPPORT RESEARCH DONE BY RESIDENTS IN ACCREDITED PROGRAMS, DEVELOP SKILLS, AND MENTORING RELATIONSHIPS HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/RESEARCHRESOURCECENTER/ FUNDINGOPPORTUNITIES/PHARMACYRESIDENTPRACTICEBASEDRESEARCHGRANT.ASPX 33 APPLICATIONS WERE RECEIVED, 6 WERE AWARDED GRANT FUNDING: - PRINCIPAL INVESTIGATOR: VICTORIA HETHERINGTON, PHARM.D., SENIOR INVESTIGATOR: PAUL BOOKSTAVER, PHARM.D. - IMPACT OF A COMPREHENSIVE STEWARDSHIP TRANSITIONS OF CARE INITIATIVE ON CLOSTRIDIUM DIFFICILE INFECTION MANAGEMENT AND CARE, PALMETTO HEALTH RICHLAND, COLUMBIA, SC - PRINCIPAL INVESTIGATOR: SONJA CLAUSEN, PHARM.D., SENIOR INVESTIGATOR: AMANDA WOLOSZYN, PHARM.D. - IMPLEMENTATION OF A PHARMACY-DRIVEN TRANSITIONS OF CARE SERVICE PROVIDING MEDICATION REVIEW, RECOMMENDATIONS, AND EDUCATION AFTER HOSPITAL DISCHARGE PRIOR TO PRIMARY CARE PROVIDER APPOINTMENT, BOZEMAN HEALTH DEACONESS HOSPITAL, BOZEMAN, MT - PRINCIPAL INVESTIGATOR: JAMIE COOK, PHARM.D., SENIOR INVESTIGATOR: EVAN SISSION, PHARMD, MSHA, BCACP, CDE - IMPLEMENTATION OF A PHARMACIST-DRIVEN CONTINUOUS GLUCOSE MONITORING PROGRAM FOR ADVANCED DIABETES MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES, VIRGINIA COMMONWEALTH UNIVERSITY, RICHMOND, VA - PRINCIPAL INVESTIGATOR: MONICA BIANCHINI, PHARM.D., SENIOR INVESTIGATOR: SUSAN DAVIS, PHARM.D. - CRITICAL CARE PHARMACY COLLABORATIVE PRACTICE TO OPTIMIZE MANAGEMENT OF SEVERE COMMUNITY ONSET PNEUMONIA, HENRY FORD HOSPITAL, DETROIT, MI - PRINCIPAL INVESTIGATOR: LOREDANA BERESCU, PHARM.D., SENIOR INVESTIGATOR: SUZANNE NESBIT, PHARM.D., BCPS, CPE, FCCP - DEVELOPING AN OPIOID STEWARDSHIP CLINICAL DASHBOARD FOR ADULT AND PEDIATRIC INPATIENT USE AT A HEALTH SYSTEM, THE JOHNS HOPKINS HOSPITAL, BALTIMORE, MD - PRINCIPAL INVESTIGATOR: LAUREN FAY, PHARM.D., SENIOR INVESTIGATOR: ROBERT DEYOUNG, PHARM.D., BCPS - THE URGENT NEED FOR URGENT CARE ANTIMICROBIAL STEWARDSHIP: EVALUATING PRESCRIBING APPROPRIATENESS AND PATIENT OUTCOMES ASSOCIATED WITH A PHARMACIST-LED CULTURE FOLLOW-UP PROGRAM, MERCY HEALTH SAINT MARY'S, GRAND RAPIDS, MI PRACTICE ADVANCEMENT DEMONSTRATION GRANTS $75,000 IN GRANTS TO SUPPORT RESEARCH TO ADVANCE PHARMACY PRACTICE THAT DEMONSTRATE OUTCOMES. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/RESEARCHRESOURCECENTER/ FUNDINGOPPORTUNITIES/PPMI-DEMONSTRATION-GRANTS.ASPX 20 LETTERS OF INTENT AND 9 FULL APPLICATIONS RECEIVED - EVALUATION OF A PHARMACIST-DIRECTED PERSONALIZED CANCER MEDICINE CLINICAL SERVICE AND DEVELOPMENT OF TOOLS ALONG WITH BEST PRACTICES TO SUPPORT PHARMACIST ADOPTION - INVESTIGATOR: J. KEVIN HICKS, PHARM.D., PH.D., H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, TAMPA, FL - IMPLEMENTING A PHARMACIST-MANAGED PERSONALIZED MEDICINE DOSING PROTOCOL FOR BETA-LACTAM ANTIBIOTICS IN CRITICALLY ILL PATIENTS: A PROSPECTIVE OBSERVATIONAL, SEQUENTIAL PERIOD, PILOT STUDY - INVESTIGATOR: MELISSA L. THOMPSON-BASTIN, PHARM.D., B.S., BCPS, UNIVERSITY OF KENTUCKY, LEXINGTON, KY PHARMACY RESIDENCY EXPANSION GRANT PROGRAM PROVIDE STIPENDS TO TRAIN ADDITIONAL RESIDENTS. HTTP://WWW.ASHPFOUNDATION.ORG/NEWPRACTITIONERGRANT PROGRAM ON HOLD FOR 2018 MATCH (NO GRANTS GIVEN OUT) PAI STATE AFFILIATE WORKSHOPS TO HELP ASHP STATE AFFILIATES LEAD STATEWIDE PAI INITIATIVES. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/RESEARCHRESOURCECENTER/ STATEAFFILIATETOOLKIT THE FOUNDATION SPONSORED 2 STATE AFFILIATE WORKSHOPS IN THE FOLLOWING STATES: GEORGIA, FLORIDA RESEARCH RESOURCES OFFERS A SET OF TOOLS TO NEW AND THOSE WHO ARE NEW TO RESEARCH. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/RESEARCHRESOURCECENTER/ RESEARCHRESOURCES.ASPX TRAINEESHIPS CRITICAL CARE TRAINEESHIP OPTIMIZE PATIENTS' MEDICATION OUTCOMES AND IMPLEMENT SERVICES IN THE CRITICAL CARE SETTING. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/TRAINEESHIPS/CRITICALCA RETRAINEESHIP 10 TRAINEES COMPLETED THE DISTANCE EDUCATION COMPONENT FROM DECEMBER 2016 THROUGH MARCH 2017 AND PARTICIPATED IN EXPERIENTIAL TRAINING IN THE SPRING OF 2017. TRAINING SITES FOR THIS PROGRAM INCLUDE: CLEVELAND CLINIC, UNIVERSITY OF ARIZONA MEDICAL CENTER, MAYO CLINIC HOSPITAL ROCHESTER, TEXAS TECH UNIVERSITY, UNIVERSITY OF CINCINNATI HEALTH UNIVERSITY HOSPITAL, UNIVERSITY OF PITTSBURGH MEDICAL CENTER, AND UNIVERSITY OF TENNESSEE. CLEVELAND CLINIC CLEVELAND, OH FACULTY: SETH BAUER, PHARM.D. NADIA ISMAIL, M.S., BPS KING FHAD UNIVERSITY HOSPITAL AL-KHOBAR, SAUDI ARABIA AI-LING POH, PHARM.D. PARKWAY HOSPITALS TELOK KURAU, SINGAPORE MAYO CLINIC HOSPITAL-ROCHESTER ROCHESTER, MN FACULTY: DR. KIRSTIN KOODA, PHARM.D., BCPS GINA PATEL, PHARM.D. INOVA ALEXANDRIA HOSPITAL ALEXANDRIA, VA UC HEALTH-UNIVERSITY HOSPITAL CINCINNATI, OH FACULTY: ERIC MUELLER, PHARM.D. CHRISTINA LEE, PHARM.D. CHILDREN'S NATIONAL HEALTH SYSTEM WASHINGTON, DC SOONALI MANIAR, PHARM.D. NEWARK BETH ISRAEL MEDICAL CENTER NEWARK, NJ MICHAEL MCQUADE, PHARM.D. CHI HEALTH- ST ELIZABETH LINCOLN, NE THE UNIVERSITY OF ARIZONA MEDICAL CENTER TUCSON, AZ FACULTY: BRIAN KOPP, PHARM.D. AMANDA HARDEN, PHARM.D. HUTCHINSON REGIONAL MEDICAL CENTER HUTCHINSON, KS JASMINE REBER, PHARM.D., M.P.H. KAISER PERMANENTE REDWOOD CITY, CA UNIVERSITY OF PITTSBURGH MEDICAL CENTER PITTSBURGH, PA FACULTY: NEAL J. BENEDICT, PHARM.D. JAIME SMITH, PHARM.D. SARATOGA HOSPITAL SARATOGA SPRINGS, NY UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY MEMPHIS, TN FACULTY: G. CHRISTOPHER WOOD, PHARM.D. PETER ZERVOPOULOS, PHARM.D., BCCCP, BCPS, BCNSP CLEVELAND CLINIC CLEVELAND, OH MEDICAL HOME TRAINEESHIP TRAIN PHARMACISTS TO OPTIMIZE MEDICATION OUTCOMES IN A MEDICAL HOME PRACTICE SETTING. 3 TRAINEES COMPLETED THE DISTANCE EDUCATION COMPONENT FROM DECEMBER 2017 THROUGH MARCH 2018 AND PARTICIPATED IN EXPERIENTIAL TRAINING IN THE SPRING OF 2018. TRAINING SITES FOR THIS PROGRAM INCLUDE: SUMMA HEALTH SYSTEM, MOUNTAIN AREA HEALTH EDUCATION CENTER, AND FAIRVIEW PHARMACY SERVICES. PARTICIPANTS: GRZEGORZ RDZAK, PHARM.D., BCPS YALE NEW HAVEN HOSPITAL NEW HAVEN, CT PRECEPTOR: SUMMA HEALTH SYSTEM MICHELLE CUDNIK MONIKA LACH, PHARM.D THE UNIVERSITY OF CHICAGO MEDICINE CHICAGO, IL PRECEPTOR: MOUNTAIN AREA HEALTH EDUCATION CENTER WILLIAM HITCH ERICA DOBSON, PHARM.D., BCPS AQ-ID, AAHIVP ACCOUNTABLE HEALTH PARTNERS ROCHESTER, NY PRECEPTOR: FAIRVIEW PHARMACY SERVICES AMANDA BRUMMEL PAIN AND PALLIATIVE CARE TRAINEESHIP TRAIN PHARMACISTS TO OPTIMIZE MED. OUTCOMES FOR PATIENTS WITH PAIN AND PALLIATIVE CARE NEEDS. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/TRAINEESHIPS/PAINMGMTTR AINEESHIP 16 PHARMACISTS WERE ACCEPTED INTO THE ADVANCED TOPICS PORTION OF THE TRAINEESHIP. EXPERIENTIAL TRAINING OCCURRED IN APRIL AND MAY 2017 AT JOHN HOPKINS HOSPITAL, THE UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY, UNIVERSITY OF IOWA HOSPITALS AND CLINICS AND SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE SCHOOL OF PHARMACY. THE JOHNS HOPKINS HOSPITAL BALTIMORE, MD FACULTY: SUZANNE AMATO NESBIT, PHARM.D., BCPS, CPE AZITA ALIPOUR, PHARM.D., BCPP, BCGP MARSHALL B. KETCHUM COLLEGE OF PHARMACY FULLERTON, CA ELIZABETH AWUDI HENRY, PHARM.D., BCPS, BCACP, BCCCP CORPUS CHRISTI MEDICAL CENTER CORPUS CHRISTI, TX SATORU ITO, PHARM.D. UNIVERSITY OF CHICAGO MEDICINE CHICAGO, IL PAIGE MALLORY, PHARM.D., R.PH., CACP EMERSON HOSPITAL BOSTON, MA SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE EDWARDSVILLE, IL FACULTY: CHRIS HERNDON, PHARM.D., FASHP ELIZABETH NICHOLS, B.A., PHARM.D. UNITYPOINT - ALLEN HOSPITAL WATERLOO, IA JESSICA RUSNAK, PHARM.D. RIVERVIEW MEDICAL CENTER ROCK HILL, SC SARAH YOST, PHARM.D., BCPS INTERMOUNTAIN PARK CITY SPINE AND PAIN CLINIC PARK CITY, UT UNIVERSITY OF IOWA COLLEGE OF PHARMACY IOWA CITY, IA FACULTY: JAMES B. RAY, PHARM.D., CPE MICHELLE AKCAR, PHARM.D. ST MARY'S MEDICAL CENTER GRAND JUNCTION, CO LAURA VOLLMER, PHARM.D., BCPS SPECTRUM HEALTH-SYSTEM GRAND RAPIDS, MI UNIVERSITY OF IOWA HOSPITAL IOWA CITY, IA FACULTY: LEE KRAL, PHARM.D., BCPS, CPE JODY BAREFOOT, PHARM.D. ALAMANCE REGIONAL MEDICAL CENTER BURLINGTON, NC RITA GAYED, PHARM.D., BCCCP GRADY HEALTH SYSTEM ATLANTA, GA NADEJE MILLS, PHARM.D. MIAMI VA MEDICAL CENTER MIAMI, FL JORDAN WULZ, PHARM.D., MPH CONCORDIA UNIVERSITY WISCONSIN MEQUON, WI UNIVERSITY OF MARYLAND BALTIMORE, MD FACULTY: MARY LYNN MCPHERSON, PHARM.D., BCPS, CPE VY OLSON, PHARM.D. VIBRA SPECIALTY HOSPITAL OF PORTLAND PORTLAND, OR MEGAN STOLLER, PHARM.D., BCPS MEMORIAL MEDICAL CENTER SPRINGFIELD, IL CRYSTAL WRIGHT, PHARM.D., BCPS, BCACP KAISER PERMANENTE GEORGIA ATLANTA, GA ANTITHROMBOTIC ASSESSMENT TOOL CREATE AND MAINTAIN A TOOL FOR HEALTH SYSTEMS TO ASSESS PREPAREDNESS TO CARE FOR PATIENTS WHO REQUIRE ANTITHROMBOTIC THERAPY. HTTP://WWW.ANTITHROMBOTICASSESSMENT.ORG/ APPROXIMATELY 344 VISITS WERE MADE TO THE SITE IN FY 18 |
| FORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS (CONTINUED) | BARCODE TOOL KIT PROVIDE TOOLS/RESOURCES TO SUPPORT THE INTEGRATION OF BARCODE USAGE IN THE MEDICATION-USE PROCESS. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/ADVANCINGPRACTICE/BARCO DE-MEDICATION-ADMINISTRATION-TOOLKIT NOT IN FY18 BUDGET, BUT THERE WERE APPROX. 550 VISITS TO THE WEBSITE IN FY18 STERILE PRODUCTS OUTSOURCING TOOL OFFER A WEB-BASED TOOL TO BE USED BY PRACTITIONERS TO EVALUATE PROPOSALS DURING THE SELECTION OF AN EXTERNAL ORGANIZATION THAT WOULD PROVIDE PARENTERAL PRODUCT PREPARATION SERVICES. HTTP://WWW.ASHPFOUNDATION.ORG/MAINMENUCATEGORIES/ADVANCINGPRACTICE/STERI LEPRODUCTSTOOL NOT IN FY18 BUDGET (NO DATA) |
| FORM 990, PART VI, SECTION A, LINE 7A | THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. |
| FORM 990, PART VI, SECTION A, LINE 8B | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION B, LINE 12C | ANNUALLY AT THE OCTOBER MEETING |
| FORM 990, PART VI, SECTION B, LINE 15A | CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVALUATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARD'S CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARMACIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 254,509. MANAGEMENT AND GENERAL EXPENSES 182,828. FUNDRAISING EXPENSES 14,722. TOTAL EXPENSES 452,059. |
| Software ID: | |
| Software Version: |